Cymabay Therapeutics Inc Revenue per Employee (CBAY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cymabay Therapeutics Inc   (NASDAQ: CBAY)
 

Cymabay Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Cymabay Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 456,956, above the company average.
Within the Healthcare sector Cymabay Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Cymabay Therapeutics Inc has 68 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBAY Revenue per Employee (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 456,956 456,118 456,118 - -
CBAY's Total Ranking # # # # #
Seq. Revenue Change - - - - -

CBAY Company Profile >> Back to CBAY Efficiency Comparisons >> Compare CBAY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 0 $ 0 $ 0
 



Financial Statements
Cymabay Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit CBAY's Income Statement
Cymabay Therapeutics Inc 's Revenues TTM $ 31 Millions Visit CBAY's aggregate revenue growth
What are CBAY's Sales? Visit CBAY's Sales by Segment




Other Ratios
Cymabay Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CBAY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CBAY's Competitors
Revenue per Employee for CBAY's Suppliers
Revenue per Employee for CBAY's Customers

You may also want to know
CBAY's Sales Growth Rates CBAY's Pe Price to earnings ratio CBAY's Receivables Turnover Ratio CBAY's Stock Quote
CBAY's Net Income Growth Rates CBAY's Ps Price to Sales ratio CBAY's Sales per Employee CBAY's Asset Turnover Ratio
CBAY's Net Margin CBAY's Pb Price to Book ratio CBAY's Financial Strength Ratios CBAY's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:05+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Pfizer Inc  789,760.00 $ 59,232.000  Million 75,000 
Genmab A  789,039.29 $ 2,390.000  Million 3,029 
Amicus Therapeutics inc   779,444.23 $ 398.296  Million 511 
Carlisle Companies Incorporated  777,440.68 $ 4,586.900  Million 5,900 
Biocryst Pharmaceuticals Inc   761,866.67 $ 331.412  Million 435 
Veru Inc   759,943.00 $ 15.199  Million 20 
Caremax Inc   751,102.00 $ 751.102  Million 1,000 
Biomarin Pharmaceutical Inc  751,079.17 $ 2,419.226  Million 3,221 
Beam Therapeutics Inc   739,156.56 $ 377.709  Million 511 
Kiniksa Pharmaceuticals International Plc  738,412.57 $ 270.259  Million 366 
Galapagos Nv  735,591.45 $ 268.491  Million 365 
Alnylam Pharmaceuticals Inc   731,316.80 $ 1,828.292  Million 2,500 
Hookipa Pharma inc   718,892.86 $ 20.129  Million 28 
Precision Biosciences Inc  716,573.53 $ 48.727  Million 68 
Eton Pharmaceuticals Inc   705,931.82 $ 31.061  Million 44 
Elite Pharmaceuticals Inc   705,850.31 $ 45.880  Million 65 
Ati Physical Therapy Inc   699,016.00 $ 699.016  Million 1,000 
Endo International Plc  686,290.69 $ 2,011.518  Million 2,931 
Eli Lilly And Company  682,482.00 $ 34,124.100  Million 50,000 
Opus Genetics Inc   680,321.43 $ 19.049  Million 28 
Rigel Pharmaceuticals Inc  671,735.63 $ 116.882  Million 174 
Xencor Inc  671,596.15 $ 174.615  Million 260 
Maravai Lifesciences Holdings Inc   664,241.38 $ 288.945  Million 435 
Corcept Therapeutics Inc  660,787.67 $ 482.375  Million 730 
Johnson and Johnson  660,667.61 $ 93,022.000  Million 140,800 
Cardiff Lexington Corporation  658,514.78 $ 11.853  Million 18 
Milestone Scientific Inc   652,840.80 $ 9.793  Million 15 
Quantum Biopharma Ltd   650,829.29 $ 4.556  Million 7 
Skinhealth Systems Inc   647,818.92 $ 397.113  Million 613 
Evoke Pharma Inc   647,578.75 $ 5.181  Million 8 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.